BOLLINGER INNOVATIONS, INC. (BINI): Nasdaq/NYSE listing notice — Bollinger Innovations receives Nasdaq delisting notice for failure to meet $35M MVLS minimum

BOLLINGER INNOVATIONS, INC.

Nasdaq notified company on Aug 26, 2025 that it failed to regain compliance with $35M MVLS minimum within 180-day cure period.
Company intends to request a hearing before Nasdaq Hearings Panel; delisting stayed pending hearing and any extension.
Company believes stockholders' equity exceeded $2.5M as of Aug 14, 2025, an alternative listing standard under Rule 5550(b).
As of Aug 29, 2025, total shares outstanding were 30,663,625.

item 3.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.92

BOLLINGER INNOVATIONS, INC. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on August 15, 2025, the Company believes that as of August 14, 2025, the Company’s stockholders' equity exceeded $2.5 million, which is an alternative standard to the MVLS Listing Rule under Nasdaq Listing Rule 5550(b). Although there can be no assurance that the Panel will grant the Company’s request for continued listing on The Nasdaq Capital Market, the delisting proceedings will be stayed and the Company’s common stock will continue to be listed on The Nasdaq Capital Market pending resolution of the ap

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BOLLINGER INNOVATIONS, INC. filing history →

Source: SEC EDGAR

accession 0001829126-25-006949

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.